David Altshuler, EVP, Global Research and CSO: Vertex Pharmaceuticals VRTX Sell · Filed 23/02/14

Trade details

Type: Insider sale
Amount: $644,695.2
Shares · price: 2,160 sh · $298.47 a share
Held after: 56,789 sh
Stock: Vertex Pharmaceuticals VRTX
Person: David AltshulerEVP, Global Research and CSO
Trade date: 23/02/13
Filed: 23/02/14
Days to filing: 1 days

Sold 3.7% of holdings

Share of holding sold: 3.7%

Vertex Pharmaceuticals trades, last 26 weeks

What else happened in Vertex Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/01/14~23/03/15

David Altshuler's recent trades

David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/19
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$22.1K
52 sh
$22.1K
Filed 25/05/15
Traded 25/05/15
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/17
Traded 25/03/13
David AltshulerEVP, Global Research and CSO
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/13
Traded 25/03/13
David AltshulerEVP, Chief Scientific Officer
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 plan
Vertex Pharmaceuticals
VRTX
$1.6M
3,231 sh
$1.6M
Filed 25/03/12
Traded 25/03/10